Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Bausch & Lomb GmbH, Brunsbütteler Damm 165-173, 13581, Berlin, Germany
Lotemax 0.5% w/v Eye Drops, Suspension.
| Pharmaceutical Form |
|---|
|
Eye-drops, suspension. Milky-white. |
The suspension contains 0.5%w/v loteprednol etabonate (5 mg/ml).
Each drop contains 0.19 mg loteprednol etabonate.
Excipient with known effect: Benzalkonium Chloride (0.01%).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Loteprednol |
Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure. |
| List of Excipients |
|---|
|
Disodium edetate |
Lotemax is available in the following packaging configurations:
2.5 mL and 5 mL supplied in a white low density polyethylene bottle (7.5 mL) with a white control drop tip and a pink polypropylene cap.
10 mL supplied in a white low density polyethylene bottle (10 mL) with a white control drop tip and a pink polypropylene cap.
Not all pack sizes may be marketed.
Bausch & Lomb GmbH, Brunsbütteler Damm 165-173, 13581, Berlin, Germany
PL 17947/0001
31/03/2008
| Drug | Countries | |
|---|---|---|
| LOTEMAX | Austria, Canada, Cyprus, Estonia, Hong Kong, Ireland, Israel, Lithuania, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
